{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:22:34Z","timestamp":1768987354990,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.urology.2020.04.104","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T23:03:12Z","timestamp":1589151792000},"page":"190-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration"],"prefix":"10.1016","volume":"142","author":[{"given":"Seyedeh-Sanam","family":"Ladi-Seyedian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.04.104_bib0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2009.07.1325","article-title":"Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review","volume":"75","author":"Bartoli","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.104_bib0002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2018.02.033","article-title":"Intradetrusor injections of botulinum toxin type A in children with spina bifida: a multicenter study","volume":"116","author":"Hascoet","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.104_bib0003","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14740338.2018.1453496","article-title":"Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder","volume":"17","author":"Rosa","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.urology.2020.04.104_bib0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpurol.2013.09.004","article-title":"Effect of onabotulinum toxin A treatment on symptoms and urodynamic findings in pediatric neurogenic bladder","volume":"10","author":"Kask","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0006","doi-asserted-by":"crossref","first-page":"1546e9","DOI":"10.1002\/nau.21124","article-title":"Repeated botulinum A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele","volume":"30","author":"Horst","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.04.104_bib0007","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.urology.2010.06.003","article-title":"Intravesical electromotive botulinum toxin type A administration\u2013part II: clinical application","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.104_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/THC-2007-15402","article-title":"Iontophoretic drug delivery system: a review","volume":"15","author":"Semalty","year":"2007","journal-title":"Technol Health Care"},{"key":"10.1016\/j.urology.2020.04.104_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","article-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens","volume":"165","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0011","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2020.04.104_bib0012","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.urology.2019.06.033","article-title":"Intravesical electromotive botulinum toxin type A (Dysport) administration in children with myelomeningocele","volume":"132","author":"Sharifi-Rad","year":"2019","journal-title":"Urology"},{"issue":"6 Pt 2","key":"10.1016\/j.urology.2020.04.104_bib0013","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/S0022-5347(05)66215-5","article-title":"Simultaneous Malone antegrade continent enema and Mitrofanoff principle using the divided appendix: report of a new technique for prevention of stoma complications","volume":"165","author":"Kajbafzadeh","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0014","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2340\/16501977-2132","article-title":"Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia","volume":"48","author":"Huang","year":"2016","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.urology.2020.04.104_bib0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11255-018-1926-6","article-title":"Non-invasive evaluation of botulinum-A toxin treatment efficacy in children with refractory overactive bladder","volume":"50","author":"U\u00e7ar","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2020.04.104_bib0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0017","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/2045772313Y.0000000116","article-title":"Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review","volume":"36","author":"Linsenmeyer","year":"2013","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.urology.2020.04.104_bib0018","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0022-5347(01)63174-4","article-title":"Intravesical electromotive drug administration technique: preliminary results and side effects","volume":"159","author":"Riedl","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0019","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.eururo.2006.08.025","article-title":"New frontiers in intravesical therapies and drug delivery","volume":"50","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00383-008-2260-3","article-title":"Botulinum toxin in pediatric urology: a systematic literature review","volume":"25","author":"Dasgupta","year":"2009","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.urology.2020.04.104_bib0021","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpedsurg.2018.05.012","article-title":"Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: a preliminary report","volume":"54","author":"Al Edwan","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.urology.2020.04.104_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.urology.2017.11.039","article-title":"Intravesical electromotive Botulinum Toxin Type \"A\" administration for management of urinary incontinence secondary to neuropathic detrusor overactivity in children: long-term follow-up","volume":"114","author":"Ladi-Seyedian","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.04.104_bib0023","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.04.104_bib0024","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520305318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520305318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:20:33Z","timestamp":1758766833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520305318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":24,"alternative-id":["S0090429520305318"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.04.104","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.04.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}